2004
DOI: 10.1136/adc.2003.029603
|View full text |Cite
|
Sign up to set email alerts
|

Mass screening for coeliac disease using antihuman transglutaminase antibody assay

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

7
121
3
7

Year Published

2005
2005
2015
2015

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 187 publications
(138 citation statements)
references
References 20 publications
7
121
3
7
Order By: Relevance
“…Similar results were reported in the Europe [3][4][5]. Some of the new studies have shown that the prevalence of CD is more than the past [3][4][5][6].…”
Section: Introductionsupporting
confidence: 78%
“…Similar results were reported in the Europe [3][4][5]. Some of the new studies have shown that the prevalence of CD is more than the past [3][4][5][6].…”
Section: Introductionsupporting
confidence: 78%
“…Serologic screening studies have shown that the worldwide prevalence of coeliac disease (CD) is to be 0.3-1.2 % in unselected European, North American, South American and Indian populations [1][2][3]. Such a rate establishes coeliac disease as one of the most common genetically based diseases.…”
Section: Introductionmentioning
confidence: 99%
“…Serologic screening studies have shown the worldwide prevalence to be 0.3-1.2% in unselected European, North American, South American, and Indian populations (Fasano et al 2003;Tommasini et al 2004;Sampson et al 2005). The factors responsible for that primary life-long intolerance in genetically predisposed individuals are wheat gliadins and other prolamins, like secalin of rye, hordein of barley, and possibly avenein of oat (Vader et al 2003).…”
mentioning
confidence: 99%